aTYR PHARMA INC (ATYR): Shares Outstanding

Annual figures by period end, from SEC filings.

98.03M
As of 2025-12-31
98.09M
As of 2026-06-30
+49.2%
3-year compound annual growth
+54.8%
5-year compound annual growth
+15.3%
10-year compound annual growth
2014-12-31: 909.9K2015-12-31: 23.67M2016-12-31: 23.74M2017-12-31: 29.79M2018-12-31: 2.19M2019-12-31: 3.89M2020-12-31: 11.02M2021-12-31: 27.79M2022-12-31: 29.50M2023-12-31: 63.29M2024-12-31: 84.04M2025-12-31: 98.03M98.03M
2014-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3198.03M+16.6%2026-03-05, Balance as of period end
2024-12-3184.04M+32.8%2026-03-05, Balance as of period end
2023-12-3163.29M+114.5%2025-03-13, Balance as of period end
2022-12-3129.50M+6.1%2024-03-14, Balance as of period end
2021-12-3127.79M+152.2%2023-03-14, Balance as of period end
2020-12-3111.02M+183.1%2022-03-15, Balance as of period end
2019-12-313.89M+78.0%2021-03-24, Balance as of period end
2018-12-312.19M-92.7%2020-03-26, Balance as of period end
2017-12-3129.79M+25.5%2019-03-26, Balance as of period end
2016-12-3123.74M+0.3%2018-03-20, Balance as of period end
2015-12-3123.67Mn/m2017-03-16, Balance as of period end
2014-12-31909.9Kn/a2016-03-30, Balance as of period end